UBS AG - AUXILIUM PHARMACEUTICALS INC ownership

AUXILIUM PHARMACEUTICALS INC's ticker is AUXL and the CUSIP is 05334D107. A total of 153 filers reported holding AUXILIUM PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 0.31 and the average weighting 0.4%.

Quarter-by-quarter ownership
UBS AG ownership history of AUXILIUM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2014$8,134,000
-40.6%
272,466
-60.1%
0.01%
-40.0%
Q2 2014$13,692,000
-2.7%
682,563
+31.9%
0.01%
-16.7%
Q1 2014$14,068,000
+868.2%
517,564
+638.7%
0.01%
+1100.0%
Q4 2013$1,453,000
+20.7%
70,064
+5.9%
0.00%0.0%
Q3 2013$1,204,000
+140.8%
66,169
+120.2%
0.00%0.0%
Q2 2013$500,00030,0540.00%
Other shareholders
AUXILIUM PHARMACEUTICALS INC shareholders Q3 2014
NameSharesValueWeighting ↓
Palo Alto Investors LP 4,883,879$101,243,0009.44%
Tamarack Capital Management, LLC 1,250,000$25,913,0006.14%
Healthcare Value Capital, LLC 334,481$6,934,0005.09%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,113,385$85,270,0004.42%
KING INVESTMENT ADVISORS INC/TX 312,890$6,486,0002.96%
Broadfin Capital, LLC 961,100$19,924,0002.63%
SECTOR GAMMA AS 462,504$9,588,0002.59%
TAMRO Capital Partners LLC 1,898,717$39,360,0001.62%
Elk Creek Partners, LLC 84,090$1,743,0001.25%
Artal Group S.A. 1,500,000$31,095,0001.12%
View complete list of AUXILIUM PHARMACEUTICALS INC shareholders